Clot risk far lower from vaccines than virus: UK study
Al Jazeera
Researchers examined data on 29 million people in England, where concerns have risen after the vaccine-related death of a BBC presenter.
The risk of rare blood clotting after receiving first doses of AstraZeneca or Pfizer COVID-19 jabs is far lower than from the virus, a large-scale study by researchers from the University of Oxford found on Friday. Fears over rare cases of clotting conditions have prompted some countries to rule out or limit rollout of the Oxford-developed AstraZeneca jab, with the United Kingdom recommending that healthy people under 40 get alternative vaccines. The study published in the BMJ medical journal examined data on 29 million people in England first vaccinated between December and April.
Director of the Kamal Adwan hospital says several staff wounded in Israeli bombardment.
Immigrant rights groups fear harsh policies and potential legal pressure could accelerate in second Trump term.
Small islands and least-developed nations say their climate finance interests were ignored.
Global lender says it will release about $333m to crisis-hit nation as signs of economic recovery emerge.
At least four people have been killed in the attack on the Basta neighbourhood, according to the Health Ministry.
A series of unexplained incidents causing damage to pipelines and cables in the Baltic Sea has occurred in the past two years. Could this be a new form of underwater warfare?
The hedge fund manager will be responsible for implementing president-elect’s pledges to cut taxes and raise tariffs.
Cola Gaza offers its drinkers an ‘apartheid-free’ alternative as they boycott big-name brands.
These were the key developments on the 1,003rd day of the Russia-Ukraine war.